Bladder Bank (a Prospective Banking Study)
NCT06109857 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2026-03-16
Summary
This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
Conditions
- Bladder Carcinoma
Interventions
- OTHER
-
Non-Interventional Study
Non-interventional study
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
John B. Kisiel, MD · Mayo Clinic in Rochester
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-06
- Primary Completion
- 2027-12-01
- Completion
- 2027-12-01
Countries
- United States
Study Locations
More Related Trials
-
Bladder Cancer Screening Trial
NCT05646485 ·Status: RECRUITING ·Phase: NA
-
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
NCT02735512 ·Status: TERMINATED
-
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.
NCT06289270 ·Status: RECRUITING
-
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
NCT03413982 ·Status: RECRUITING
-
Drug Screening Using IMD in Bladder Cancer
NCT06204614 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
NCT06986304 ·Status: RECRUITING
-
Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer
NCT02969109 ·Status: COMPLETED
-
Screening for Bladder Cancer
NCT00848627 ·Status: COMPLETED
-
A Diagnostic for the Early Detection of Bladder Cancer
NCT05347342 ·Status: ACTIVE_NOT_RECRUITING
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
NCT07187063 ·Status: RECRUITING ·Phase: NA
-
PENK Methylation Test for Detecting Bladder Cancer
NCT05220189 ·Status: RECRUITING
-
Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection
NCT05767528 ·Status: UNKNOWN
-
Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma
NCT00867620 ·Status: UNKNOWN
-
Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool
NCT06878027 ·Status: RECRUITING
-
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
NCT05982561 ·Status: RECRUITING
-
Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay
NCT05643690 ·Status: SUSPENDED
-
Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population
NCT06992986 ·Status: RECRUITING
-
Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
NCT07029256 ·Status: RECRUITING
-
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734 ·Status: ACTIVE_NOT_RECRUITING
-
Personalized Urine Biomarker for Patients With Bladder Cancer
NCT05467267 ·Status: UNKNOWN
-
Establishment and Validation of an Early Diagnostic Model for Bladder Cancer Based on Serum and Urine Metabolomics
NCT04966962 ·Status: UNKNOWN
-
Microscopic-spectroscopic Examination for Urothelial Tissue Characterization
NCT04310813 ·Status: COMPLETED
-
Prognostic Biomarkers in Patients With Urothelial Carcinoma
NCT04872036 ·Status: COMPLETED
-
Prospective Bladder Cancer Infrastructure (ProBCI)
NCT04503577 ·Status: RECRUITING